Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond K Cross

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Gastroenterology & Hepatology|July 1, 2014
Telemanagement for inflammatory bowel diseaseRaymond K Cross
Inflammatory Bowel Diseases|September 15, 2017
Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative ColitisRaymond K Cross
Expert Review of Gastroenterology & Hepatology|April 28, 2015
Which patients with inflammatory bowel disease should receive combination therapy?Raymond K Cross
The American Journal of Gastroenterology|June 28, 2018
Is There a Role for Thiopurines in IBD?Raymond K Cross, Hans Herfarth
Inflammatory Bowel Diseases|July 6, 2016
Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and DifferencesAnita Afzali, Raymond K Cross
Inflammatory Bowel Diseases|February 8, 2020
Just Say No…to the Nocebo EffectLeah Rossmann, Raymond K Cross
Clinical Trials (London, England)|October 14, 2009
Challenges in the design of a Home Telemanagement trial for patients with ulcerative colitisRaymond K Cross, Joseph Finkelstein
Drug Design, Development and Therapy|February 7, 2023
Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn's Disease: Patient Selection and Reported OutcomesSara Horst, Raymond K Cross
Gastroenterology|May 2, 2022
Chicken or Egg, Mental Health Disorders in Inflammatory Bowel Disease: Does It Matter?Raymond K Cross, Laurie Keefer
Inflammatory Bowel Diseases|August 15, 2019
Is Endoscopic Remission in Ulcerative Colitis Still Good Enough?Sumona Bhattacharya, Raymond K Cross
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Gastroenterology & Hepatology|July 1, 2014
Telemanagement for inflammatory bowel diseaseRaymond K Cross
Inflammatory Bowel Diseases|September 15, 2017
Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative ColitisRaymond K Cross
Expert Review of Gastroenterology & Hepatology|April 28, 2015
Which patients with inflammatory bowel disease should receive combination therapy?Raymond K Cross
The American Journal of Gastroenterology|June 28, 2018
Is There a Role for Thiopurines in IBD?Raymond K Cross, Hans Herfarth
Inflammatory Bowel Diseases|July 6, 2016
Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and DifferencesAnita Afzali, Raymond K Cross
Inflammatory Bowel Diseases|February 8, 2020
Just Say No…to the Nocebo EffectLeah Rossmann, Raymond K Cross
Clinical Trials (London, England)|October 14, 2009
Challenges in the design of a Home Telemanagement trial for patients with ulcerative colitisRaymond K Cross, Joseph Finkelstein
Drug Design, Development and Therapy|February 7, 2023
Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn's Disease: Patient Selection and Reported OutcomesSara Horst, Raymond K Cross
Gastroenterology|May 2, 2022
Chicken or Egg, Mental Health Disorders in Inflammatory Bowel Disease: Does It Matter?Raymond K Cross, Laurie Keefer
Inflammatory Bowel Diseases|August 15, 2019
Is Endoscopic Remission in Ulcerative Colitis Still Good Enough?Sumona Bhattacharya, Raymond K Cross
Pageof 21